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Abstract Substance-using men who have sex with men
(MSM) are among the groups at highest risk for HIV
infection in the United States. We report the results of a
randomized trial testing the efficacy of a small group
sexual and substance use risk reduction intervention based
on empowerment theory compared to an enhanced effica-
cious control condition among 515 high risk not-in-treat-
ment MSM substance users. Effect sizes for sexual risk and
substance use outcomes were moderate to large: HIV
transmission risk frequency, d = 0.71 in the control versus
0.66 in the experimental group; number of anal sex part-
ners, d = 1.04 versus 0.98; substance dependence symp-
toms, d = 0.49 versus 0.53; significant differences were
not observed between conditions. Black MSM reduced
their risks at a greater rate than White or Latino men. The
findings point to a critically important research agenda to
reduce HIV transmission among MSM substance users.
Keywords MSM  HIV  Substance use  Sexual risk 
Behavioral intervention
Introduction
According to recent CDC estimates, men who have sex
with men (MSM) account for more than 60 % of all new
infections in the United States [1]. Given that the majority
of all new infections in the United States occur among
MSM, finding ways to identify and lower transmission
rates in this group is key to lowering HIV incidence rates in
the United States. We now have evidence, compiled over
the past 30 years, to show that substance-using MSM are
among the groups at highest risk for HIV infection in the
United States [2–5]. Furthermore, two independent analy-
ses using HIV seroconversion end-points found that about a
third of new HIV infections among MSM can be attributed
to non-injection substance use [6, 7]. This body of epide-
miological and behavioral research makes it clear that if we
are to reduce rates of HIV transmission among MSM in the
United States, strategies that are specifically designed to
lower risks among substance-using MSM must be an
essential component of any successful response to the
epidemic in this population.
Despite widespread agreement that substance-using
MSM suffer a large proportion of new HIV infections in
the United States, the vast majority of research among
MSM substance users has been descriptive in nature. As
such, evidenced-based risk reduction interventions for not-
in-treatment MSM substance users are lacking [8–11]. To
date, there have been only four randomized controlled
trials (RCTs) to reduce HIV risk among MSM substance
users [12–14], the most recent of which is the subject of
this report. The earlier RCTs testing new interventions for
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MSM substance users all demonstrated high levels of risk
reduction in both the experimental and control conditions,
but differences in behavior change reached statistical sig-
nificance between conditions in only one of these studies,
which was implemented among men in substance abuse
treatment [13].
We tested the efficacy of a novel small group sexual and
substance use risk reduction intervention based on psy-
chological empowerment theory [15] compared to an
enhanced efficacious [16] HIV risk-reduction counseling
condition among high risk not-in-treatment MSM sub-
stance users in South Florida (Miami/Ft. Lauderdale). The
small group intervention approach, and to a somewhat
lesser extent the control condition, conceptualized sexual
risk behaviors and substance use primarily as symptoms of
underlying life problems related to the substance use,
violence, and AIDS syndemic [17] present in this popula-
tion. This paper presents outcome data comparing an
enhanced efficacious intervention that is already part of
standard HIV risk-reduction public health practice to a new
intervention specifically designed for substance using
MSM.
Methods
Site
South Florida (Miami/Ft. Lauderdale) is a well-known
migration destination for MSM, with the second highest
proportion of same-sex households among large cities in
the nation [18]. The Miami metropolitan area reports the
highest HIV and AIDS incidence rates in the U.S. [19]. A
recent Miami study found that almost half (45 %) of HIV-
positive MSM were unaware of their infection [20].
Baseline data from the present study indicated that almost
one-third of HIV-negative men who migrated to South
Florida after the age of 18 seroconverted within 5 years of
doing so [21], making the study site one of the highest risk
settings for HIV seroconversion among MSM in the United
States.
Study Sample
The study was designed to recruit a sample of 500 partic-
ipants, in order to achieve 0.85 power to detect a 0.25
effect size reduction in HIV transmission risk events,
assuming 20 % attrition over 12 months.
Participants (N = 515) were recruited between Novem-
ber 2008 and October 2010 through multiple methods,
including direct outreach, participant referral, and internet
and print media. Eligible men were between the ages of 18
and 55; reported multiple anal sex partners and at least one
unprotected anal intercourse (UAI) event with a non-
monogamous partner in the past 90 days; met one or more
of three substance use inclusion criteria: binge drinking
(five or more drinks) at least three times, drug use
(excluding marijuana) at least three times, and/or marijuana
use at least 20 days, in the past month; resided in South
Florida and intended to remain there through the term of
study participation; and provided a mailing address and
personal telephone number. Men were ineligible if they
were newly diagnosed with HIV infection in the prior
6 months (including tests at study enrollment) or if they
participated in an HIV or substance use prevention inter-
vention or substance abuse treatment program in the prior
12 months. Follow-up interviews were completed in
December 2011.
Procedures
The study was conducted at two field offices, one in Wilton
Manors (a suburb of Ft. Lauderdale) and one in Miami
Beach. The offices were located in standard business office
buildings; the Wilton Manors office building was located
on the site of a community based organization. Both of
these neighborhoods serve as the dominant residential,
gathering and recreational centers for MSM in South
Florida, are located in adjoining counties, and are situated
close enough to each other that there is substantial move-
ment by MSM between the two neighborhoods. Men
responding to recruitment messages called the nearest field
office and were screened to determine eligibility over the
telephone. Those who were eligible and expressed interest
in participating were asked to visit the field office, where
staff members rescreened for eligibility and administered
informed consent using procedures approved by the Uni-
versity of Delaware’s Institutional Review Board (prede-
cessor institution for the project). Following consent,
locator data were collected, men reporting HIV-negative
serostatus were offered confidential testing, and all enrol-
lees were scheduled for a second appointment for baseline
assessment. Enrollees were paid a $20 stipend for their
time and travel expenses.
At the second appointment, all respondents completed a
standardized baseline assessment based on the Global
Appraisal of Individual Needs (GAIN, v. 5.4) [22]. Private
offices were used for all assessments using computer-
assisted face-to-face interviewing procedures. These inter-
views lasted approximately an hour and a half. Following
completion of the baseline assessment, participants were
randomized to the small group or control intervention
conditions using a computer-generated random number
table. In order to make sure that the experimental inter-
vention small groups (N = 5–10) could be formed within a
short period of time after participants’ baseline assessments
AIDS Behav (2013) 17:2914–2926 2915
123
were completed, randomization proceeded in blocks of 20.
Field office staff and participants were blinded to random-
ization until immediately after the baseline interview. Par-
ticipants were aware that some were assigned to a small
group discussion condition and others to an individual
counseling format. Follow-up interviews at 3, 6, and
12 months after intervention completion (1 week for the
control arm and 5 weeks for the experimental arm) included
the same items as the baseline instrument, exclusive of life
history items, and lasted about 1 h. Participants were
offered HIV education literature, condoms, and a $50 sti-
pend upon completing each assessment.
Staff
The field offices were staffed by MSM age-peers with a
minimum of a Bachelor’s degree, 1 year of prior research
experience, and demonstrated commitment to MSM health.
In addition to being trained in the recruitment procedures,
data collection instruments, and intervention protocols, all
staff completed requirements for State of Florida certifi-
cation as HIV test counselors. Field staff also completed
20 h of motivational interviewing (MI) training conducted
by a professional MI trainer. Experimental and control arm
intervention protocols were delivered by the same staff
members. The dissimilarities of the intervention formats
and intensities, together with regular monitoring of all
intervention delivery components for fidelity, minimized
risk of contamination across arms.
Interventions
The design of the 4-session small group experimental arm
of the study was grounded in psychological empowerment,
the process by which people gain mastery of issues of
concern to them [23]. In an individual context, empow-
erment is a process through which individuals come to
perceive a connection between their goals and the means
to achieve them, and between their efforts and the desired
results [24]. Psychological empowerment theory asserts
that goals can be achieved based on one’s efforts to fulfill
those goals, but achievement is also subject to interactions
among current risk factors (social isolation, substance
use), strengths (perceived control, coping skills, critical
awareness), and awareness of resources [23]. The con-
ceptual model guiding the intervention approach, which
was developed during extensive pilot qualitative research
and a small preliminary efficacy trial [25, 26], is shown in
Fig. 1.
Given this background, the experimental intervention
focused on assisting high risk MSM substance users in: (1)
strengthening the skills needed to exercise control over their
lives; and (2) taking a third person view of the interac-
tions of drugs and sex among gay men, and examining the
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good and bad experiences associated with them; (3)
broadening their spheres of social engagement; and, (4)
identifying achievable life goals and action plans to move
toward them.
The intervention employed two main tools to help men
achieve these aims: (1) guided group discussions that
emphasized the building of trust and intimacy with other
men, and the sharing of men’s diverse experiences, strengths,
and approaches to problem solving; and, (2) individual take
home exercises that promoted self-awareness, social diag-
nostic skills, and social connectedness. The primary group
intervention components by session are outlined in Fig. 2.
In accordance with psychological empowerment theory,
goals were entirely participant-identified, and included a
wide diversity of efforts, such as: educational, vocational,
hobby and volunteering pursuits; substance abuse treatment
entry; changing friendship networks; and exiting abusive
relationships. Intervention sessions were scheduled 1 week
apart. Each group session lasted about 2 h, and was facil-
itated by two staff members. Participants who missed a
group session were invited to attend the other sessions for
their group, but they were not permitted to attend other
groups for the session(s) they missed.
One week after completion of the four group sessions,
men in the experimental arm of the study attended an
individual goal achievement counseling session with a staff
member. In keeping with the psychological empowerment
framework, staff used an extensive compendium of
resources, including health and social services and oppor-
tunities for employment, education and social engagement
Session 3
Discussion:
A. Alcohol and drugs: meanings and motivations; benefits and drawbacks; relationship to sex, 
boredom and loneliness; risk reduction measures. Identify strengths we can use to exercise 
control and make changes.
B. Taking control and managing stress: creating a social safety net; setting and achieving 
goals; new stress relief techniques.
Homework: Goal setting; joining an organization; stress reduction. 
Session 4
Discussion:
A. Taking control of your place in the gay scene.
B. Pairs exercise: setting goals and making changes.
Homework: goal setting; social participation; friendship; sexual intimacy.
Session 2
Icebreaker
Discussion:
HIV serostatus, disclosure and safer sex: HIV-based identities; stigma and segregation; 
diversity of perspectives and behaviors; sensation seeking; intimacy; barriers to safer sex.  
Identify strengths we can use to exercise control and make changes.
Homework: Gay venue observation - drug use; quality time with a friend; sexual intimacy.
Session 1
Icebreaker
Discussion:
A.  Coming out; experiences of secrecy and social support.  Identify strengths (e.g., self-
reliance, self-awareness, cultural resistance) used to take control of problems.
B.  Managing gay/bi life in South Florida: dating and sex; community; friendships; competition; 
homophobia.  Identify strengths we can use to exercise control and make changes.
Homework: Gay venue observation - social behaviors; quality time with a friend; sexual intimacy.
Session 5 (individual)
Goal achievement plan
- Action steps
- Identifying barriers and ways to overcome them
- Resource identification and referrals 
Comprehensive referrals for health and social services
Fig. 2 Group intervention
session content
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to assist men in identifying action plans to initiate the
achievement of the goals they identified for themselves
during the group sessions. Potential barriers to goal
achievement were also discussed, as well as possible ways
these might be overcome. Comprehensive referrals were
made for any health and social service needs. Individual
counseling sessions lasted about 1 h.
The single session individual control condition included
sexual and substance use risk assessment and risk reduction
counseling using the RESPECT model [16]. Because of the
high levels of vulnerability and need of the target population,
and guided by a resilience theoretical framework that focuses
on assets and resources to overcome risk [27], we enhanced
the control condition based on key domains of resilience that
emphasize understanding and separating oneself from risk,
strengthening positive relationships, and fostering initiative,
creativity and morality [28]. Examples of the implementa-
tion of these approaches included re-forming friendship
networks to reduce substance use, using humor to negotiate
condom use, and taking the initiative to develop alternative
social engagements to drugs-sex involvement. Each session
lasted 30–45 min, and concluded with a written individual-
ized risk reduction plan. Staff used the same compendium of
resources as for the experimental arm to assist with referrals
to needed health and social services.
All intervention sessions were audio recorded; tran-
scripts of all group discussions were reviewed for fidelity
to the intervention protocols, as were 20 % of all individual
counseling sessions. Participants in both study arms were
offered condoms and a $30 stipend to cover time and travel
costs at the completion of each intervention session.
Measures
Sexual Risk Behaviors
Sexual behavior measures at each assessment included
counts of past 90 day receptive and insertive anal inter-
course events, with or without a condom, with a casual or
primary partner, and with a seroconcordant, serodiscordant,
or unknown serostatus partner. Study eligibility require-
ments excluded men in monogamous relationships, so that
unprotected sex with both primary and casual partners was
considered risk behavior. Participants answered inter-
viewers’ questions about these behaviors by completing a
chart of responses such that parent items (e.g., ‘‘how many
times did you have receptive anal sex without a condom’’)
were followed by sub-items (e.g. how many times with an
HIV?, HIV- and HIV-unknown partner), and the totaled
sub-items were equal to the related parent item frequency.
The sexual risk inventory included a total of 21 items and
took about 10 min to administer. Because uptake of HIV
testing at study enrollment was low (many participants said
they already had another preferred testing venue), partici-
pant HIV status was assessed by self report, and seropos-
itivity was verified with a notice of diagnosis or ARV
prescription.
Substance Use
Substance use measures at each assessment included past
90 day frequency of use of each substance, including binge
drinking (five or more drinks at one sitting) and the non-
medical use of prescription medications. We also inquired
how often each substance was used before or during sex in
the past 90 days. DSM-IVR substance dependence was
determined by the endorsement of three or more of seven
dependence symptoms (e.g. needing more drug to get the
same effect, experiencing withdrawal symptoms, being
unable to quit or cut down) in the past 90 days.
Syndemic Symptoms
We report several measures of syndemic factors to more
comprehensively describe the sample. The General Mental
Distress Scale (GMDS) is comprised of past year DSM-
IVR symptom counts for depression (nine items), anxiety
(12 items), and somatic disorders (four items). This scale is
reducible to classifications indicating clinical significance
(subclinical, moderate and severe) [22] and was further
dichotomized in the analyses presented here into ‘‘severe’’
and ‘‘not severe.’’ Alpha reliability coefficients for the
depression, anxiety, and somaticism subscales in this study
were 0.822, 0.829, and 0.706, respectively. Victimization
was assessed by affirmative responses to the following
events: being attacked with a weapon or being beaten so as
to cause bruises, cuts or broken bones (physical abuse);
being forced to participate in sexual acts against one’s will
(sexual abuse); or being made to feel very bad about
oneself or one’s life (emotional abuse). For analysis, we
used a summary measure: any lifetime abuse vs. no abuse.
We constructed a separate variable to identify participants
whose first experience of abuse occurred when they were
minors.
Outcome Measures
The primary outcome measure is frequency of unprotected
anal intercourse (UAI) involving HIV transmission risk
(i.e. excluding UAI where both partners were HIV-posi-
tive). We selected this measure, which includes UAI
between men who believe they are HIV-negative, because
of the large number of HIV-positive men in South Florida
who are unaware of their status [20], and because the
high rates of UAI and partner change reported by the
HIV-negative men in our sample render serosorting an
2918 AIDS Behav (2013) 17:2914–2926
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ineffective risk reduction strategy for them [29]. We note,
however, that the intervention effects on the primary out-
come measure did not substantially differ if other defini-
tions of sex risk were used, neither the broader measure of
any UAI, nor the narrower measure of UAI with serodis-
cordant or unknown serostatus partners. We report mean
outcome data for any UAI to show the similarity of results
across the two measures. Secondary outcome measures,
using past 90 day recall periods, include: (1) receptive and
insertive HIV transmission risk frequencies, (2) numbers of
anal sex partners, (3) frequency of binge drinking or using
drugs before or during sex, and (4) DSM-IVR substance
dependence symptoms.
Data Analyses
The level of significance was set at p \ 0.05 for all tests.
Data from the interview questionnaires were analyzed
using Stata/SE 12.1 for Windows. There were no missing
data from any completed assessments. Descriptive statistics
were calculated to describe the sample by intervention
condition in terms of demographics; HIV serostatus; past
90 day substance use and sexual risk behaviors; mental
distress; substance dependence; and victimization history.
All outcomes were examined on an intent-to-treat basis,
and included all of the data available for each follow-up
wave. For the baseline to 3 month outcomes, there were
467 cases available for analysis; for baseline to 6 months,
459 cases; and for baseline to 12 months, 453 cases.
Because the outcome measures—had positively skewed
distributions, we used log transformations of these mea-
sures for the longitudinal analyses (although the substance
dependence measure was not highly skewed, we report the
log transformed measure for consistency). The transfor-
mations not only reduced the rightward skew of the data,
but they also reduced the effect of right side outliers that
were predominant in the control group. Baseline differ-
ences and longitudinal effect sizes for these measures are
reported for the log-transformed measures.
To examine change over time in the primary and sec-
ondary outcomes, we constructed multilevel non-linear
growth models (MLM) for repeated measures, controlling
for age, age * time interaction, race/ethnicity, race/ethnicity
* time interaction, HIV serostatus, HIV serostatus * time
interaction, arm, and arm * time interaction. These models
take all available measurement points into account, and
quantify the slope and shape of the behavior change curves
over the three follow-up points. In addition to differences in
behavior change by intervention condition, the models
indicate whether there were significant differences in
baseline outcome measures and rates of behavior change by
demographic variables (e.g. Black race, HIV serostatus). In
accordance with the Consolidated Standards of Reporting
Trials statement, we also report a summary of outcome
results by study condition, including Cohen’s d effect size
statistics and related 95 % confidence intervals. Effect sizes
and confidence intervals are reported for the log-trans-
formed measures.
Results
Sample Characteristics
Sample characteristics at baseline by study condition are
shown in Table 1. The sample was diverse as to age, race/
ethnicity, and serostatus, and averaged almost 2 years of
college education. Substance use was also diverse, with the
large majority (81.2 %) reporting binge drinking. About
two-thirds (62.3 %) reported illicit stimulant (cocaine,
crack, and/or methamphetamine) use, 53.4 % amyl nitrites,
34.4 % prescription sedatives and 25 % prescription opi-
oids. Numerous other substances were reported but did not
exceed 20 % prevalence.
By any measure, the study participants reported extraor-
dinarily high rates of HIV risk behaviors and related psy-
chosocial/syndemic health conditions. Participants reported
an average of more than 13 anal sex partners and 16 HIV
transmission risk events in the past 90 days, for an average of
about one new anal sex partner and high risk HIV trans-
mission event each week. Majorities met criteria for severe
mental distress (57.9 %) and substance dependence
(62.1 %), and had been victimized as minors (54.8 %). The
intervention groups were not significantly different on any of
these measures, except that the control group reported more
frequent use of sedatives at baseline.
The control group also reported higher frequencies on
most sexual risk measures, but these did not approach the
0.05 level of significance. As noted in the ‘‘Methods’’
section, the log transformations substantially attenuated the
effect of right side outliers that predominated in the control
group. Skewness in the sexual risk variables ranged from
3.37 to 5.55, and was reduced in the log-transformed
variables to a range of 0.28 to 0.99.
Enrollment, Retention and Adverse Events
The participant flow chart is shown in Fig. 3. The most
common reasons for failing the initial eligibility screen
were: sexual risk threshold (64.5 %); substance use
threshold (20.8 %); both sexual risk and substance use
thresholds (13.5 %); and recent enrollment in a drug treat-
ment or HIV prevention program (13.7 %). In total, 515
men were randomized into the study. Four hundred-twenty
participants (81.6 %) completed all four assessments, 47
AIDS Behav (2013) 17:2914–2926 2919
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(9.1 %) completed baseline plus two follow-ups, 25 (4.9 %)
completed baseline plus one follow-up, and 23 (4.5 %)
completed only the baseline assessment. Participants lost to
all follow-up and those who did not complete the 12-month
assessment did not differ from other participants on mea-
sures of race/ethnicity, income, mental distress, victimiza-
tion history, substance use, substance dependence, or sex
risk. Men lost to all follow-up and to the 12 month
assessment were about 5 years younger, on average, than
other participants. Although a number of participants
experienced drug overdose, medical problems and/or vic-
timization over the course of the study, no adverse events
were attributable to study participation.
Study Outcomes
Table 2 displays the results of the MLMs of longitudinal
changes in the frequencies of the log transformed primary
and secondary outcome measures, controlling for age, race/
ethnicity, HIV serostatus, and arm, and their interactions
with time. Results for the primary outcome measure, HIV
transmission risk frequency, are shown in the first column.
The observed decrease in HIV transmission risk events was
significant at the p \ 0.001 level for the entire sample.
Time^2, the quadratic term indicating rate of change, is
also significant and indicates a nonlinear and decreasing
rate of reduction in the outcome variable over time. There
Table 1 Baseline characteristics of substance-using MSM by intervention condition N = (515)
Experiment (N = 252) Control (N = 263) Chi square
or t statistic
p
N % N %
Demographics
Agea 39.21 (9.41) 38.66 (9.88) 0.640 0.522
Education in yearsa 13.98 (2.39) 13.71 (2.32) 1.314 0.189
Ethnicity:
Hispanic 73 29.0 60 22.8 2.545 0.111
African American/Caribbean 51 20.2 57 21.7 0.160 0.689
White 117 46.4 133 50.6 0.884 0.347
Other 11 4.4 13 4.9 – –
HIV-positive 113 44.8 126 47.9 0.487 0.485
Substance use (past 90 days)
Alcohol (binge drinking) 202 80.2 219 83.3 0.835 0.361
Amyl nitrites (poppers) 133 52.8 142 54.0 0.076 0.782
Cocaine (powder) 115 45.6 116 44.1 0.122 0.727
Methamphetamine 67 26.7 65 24.7 0.237 0.627
Crack cocaine 46 18.3 58 22.1 1.153 0.283
Rx sedatives 74 29.4 103 39.2 5.478 0.019*
Rx opioids 54 21.4 75 28.5 3.444 0.063
Sexual behaviors (past 90 days)
Anal intercourse frequencya,b 29.58 (35.00) 36.55 (50.69) 0.888 0.375
HIV transmission risk frequencya,b 13.92 (25.21) 18.89 (37.03) 1.373 0.170
Anal intercourse partnersa,b 11.94 (15.19) 14.50 (21.27) 0.907 0.365
Used drugs for sex frequencya,b 42.94 (68.01) 44.82 (59.84) 1.119 0.264
Syndemic factors
Severe mental distress 149 59.1 149 56.7 0.323 0.570
DSM-IVR substance dependence 152 60.3 168 63.9 0.694 0.405
Victimization history (lifetime) 212 84.1 213 81.0 0.879 0.348
First abuse before age 18 145 57.5 137 52.1 0.712 0.399
a Mean (SD)
b t statistics and p-values obtained after log transformation
* Significant difference between groups
2920 AIDS Behav (2013) 17:2914–2926
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are no age or racial/ethnic differences at baseline, but
Black men reduced their HIV transmission risk frequency
at a 17 % greater rate over time than Hispanic men
(p \ 0.01) and 18 % greater than White men (p \ 0.01).
HIV positive men had much lower rates of HIV trans-
mission risk events than HIV-negative men at baseline
(p \ 0.001), because the outcome variable excluded UAI
events where both partners were HIV-positive. There was
no difference by serostatus in rate of change in HIV
transmission risk frequency over time. No significant dif-
ferences in outcome between the experimental and control
conditions were observed.
The results are similar for receptive and insertive HIV
transmission risk frequencies, shown in the second and
third columns of Table 2. There were two differences in the
receptive transmission risk model: there was no significant
difference between Black and Hispanic men in rate of
behavior change; and there were no significant differences
in baseline receptive transmission risk frequencies by
serostatus. Change in numbers of anal sex partners is
shown in column 4. The patterns are similar to those for
HIV transmission risk frequency, except that HIV-positive
participants reported 29 % (p \ 0.001) more partners at
baseline compared to HIV-negative men. No significant
differences in outcome between the experimental and
control conditions were observed.
Change in frequency of using drugs/binge drinking
before or during sex is shown in column 5 of Table 2.
Patterns of behavior change are similar to those observed
for number of anal sex partners, except that Black men
reported 37 % higher frequency of binge drinking before or
during sex than Hispanic men (p \ 0.05) and 44 % higher
frequency than white men (p \ 0.01) at baseline. Similar to
the other outcome measures, however, black men reduced
their use of drugs/binge drinking for sex at a faster rate than
White and Hispanic men over the course of the study. No
significant differences in outcome between the experi-
mental and control conditions were observed.
Change in substance dependence symptoms is shown in
column 6. As for the other outcome measures, the observed
decrease in symptoms was significant at the p \ 0.001
level for the entire sample. Time^2, the quadratic term
indicating rate of change, is also significant and indicates a
nonlinear and decreasing rate of reduction in the substance
dependence symptoms over time. Black men reported more
symptoms than White men at baseline (p \ 0.01). HIV
positive men reported more symptoms than HIV-negative
at baseline (p \ 0.01). No differences in rates of change by
demographics were observed, and there were no significant
differences in outcome between the experimental and
control conditions.
Wave by wave changes in the mean values of primary
and secondary outcome measures are shown in Table 3
(total UAI frequency is also shown to demonstrate the
similar result to HIV transmission risk frequency). As
indicated by the results of the multilevel models in Table 2,
reductions in sexual risk behaviors, substance use, and
substance dependence symptoms were greatest between
baseline and 3 month follow-up, with rather modest
changes thereafter.
Effect sizes for the changes in the log transformed pri-
mary and secondary outcome measures between baseline
and 12 month follow-up by study arm are also shown in
Table 3. Effect sizes were moderate to large across all
outcomes, and no significant differences were observed
between study conditions. The effect size for the reduction
in substance dependence symptoms was moderate (0.49 in
the control group vs. 0.53 in the experimental group).
Effect sizes for all main sexual risk outcomes were large:
Experimental Condition
N=252
Attendance:
Session 1     216 (86%)
Session 2     215 (85%)
Session 3     210 (83%)
Session 4     195 (77%)
Session 5     232 (92%)
Comparison Condition   
N=263
Attendance:
Session 1    261 (99%)
Assessed and Randomized
N=515
Follow-up 
Assessments
Attendance:
3-month        220 (87%)
6-month        224 (89%)
12-month      223 (88%)
Follow-up 
Assessments
Attendance
3-month        247 (94%)
6-month        235 (89%)
12-month      230 (87%)
Completed Screen 2   (N=711)
Excluded:
112   Ineligible
17   Declined
3   Expired time
3   New HIV+ 
59   No show for baseline
2   Double enrollment
Completed Screen 1 (N=2300)
Excluded:
1440   Ineligible
929    No recent UAI
299    No recent substance use
195    No recent UAI or substance use
197    Recent drug treatment / HIV interv.
27    Age
42   Declined
107   No show for Screen 2
Fig. 3 Study flow chart
AIDS Behav (2013) 17:2914–2926 2921
123
HIV transmission risk frequency, 0.71–0.66; number of
anal sex partners, 1.04–0.984; and frequency of using
alcohol and/or drugs for sex, 0.94–1.00. Effect sizes for
receptive and insertive HIV transmission risk frequencies
separately were moderate.
Discussion
The risk reductions reported by the high risk MSM sub-
stance users in this study are as large or larger than those
achieved by other efficacious interventions for MSM now
being diffused as tools in standard public health practice
[10, 30], and are particularly impressive given their
achievement in such a high risk population. The results
indicate that intervention approaches for substance using
MSM that target empowerment and resilience—the iden-
tification and achievement of life goals, building positive
social relationships, broadening social engagements, and
improving coping skills, self-efficacy and self worth—
appear to be efficacious based on pre- and post-intervention
self reports of behavior change, and may lead to more
sustainable behavior change than addressing sexual risk
behaviors and drug use with educational or didactic
approaches. Moreover, resilience-based interventions have
demonstrated efficacy in reducing substance use and
mental distress in other populations [31–34].
Although in designing the study we strongly believed
that group process would be an important element in
assisting high risk substance using men to legitimize,
embrace and enact the proficiencies targeted by empower-
ment theory, men in the single-session individual counsel-
ing arm reported reductions in their sexual and substance
use risk behaviors to the same extent as the men in the four-
session group condition. Although a finding of no difference
between arms of an RCT study is often interpreted as evi-
dence of a failed trial of an innovative intervention, it is
important to point out that in this case the comparisons were
between an intervention with proven efficacy, which we
enhanced based on resilience theory, and a novel
Table 2 Multilevel model of longitudinal change in past 90 day outcomes (log-transformed) (N = 515)
Column 1 2 3 4 5 6
Variable HIV trans. risk
frequency
Receptive trans.
risk frequency
Insertive trans.
risk frequency
Anal sex
partners
Used drugs for
sex frequency
Subst. depend.
symptoms
Estimate S.E. Estimate S.E. Estimate S.E. Estimate S.E. Estimate S.E. Estimate S.E.
Fixed effects :
Intercept 2.45 0.26 1.60 0.25 1.62 0.24 1.98 0.19 2.82 0.27 1.41 0.14
Time -1.07 0.12 -0.63 0.10 -0.72 0.11 -0.88 0.09 -1.14 0.14 -0.34 0.07
Time^2 0.19 0.02 0.13 0.02 0.11 0.02 0.17 0.01 0.24 0.02 0.05 0.01
Age -0.003 0.006 -0.01 0.006 0.004 0.006 -0.000 0.004 0.01 0.006 -0.006 0.003
Age*Time 0.001 0.002 0.00 0.002 0.000 0.002 -0.001 0.002 -0.003 0.003 0.001 0.002
Race (ref. Black)
Hispanic -0.07 0.16 0.08 0.15 -0.20 0.15 0.02 0.12 -0.37* 0.16 -0.08 0.09
White 0.003 0.14 0.11 0.13 -0.12 0.13 0.06 0.10 -0.44** 0.14 -0.23** 0.08
Other -0.06 0.27 0.07 0.26 -0.18 0.25 0.19 0.19 0.17 0.27 -0.10 0.15
Hispanic*Time 0.17** 0.06 0.07 0.05 0.16** 0.06 0.11* 0.05 0.18* 0.07 0.02 0.04
White*Time 0.18** 0.06 0.10* 0.05 0.12* 0.05 0.13** 0.04 0.27 0.06 0.04 0.03
Other*Time 0.10 0.10 0.05 0.09 0.03 0.09 0.12 0.08 0.01 0.12 0.005 0.06
HIV status (ref. neg) -0.66 0.11 -0.12 0.11 -0.77 0.10 0.29 0.08 0.28* 0.11 0.18** 0.06
HIV status*Time 0.01 0.04 0.05 0.04 0.08* 0.04 -0.03 0.03 -0.03 0.05 -0.004 0.03
Arm (ref. Control) -0.17 0.11 -0.14 0.10 -0.08 0.10 -0.06 0.08 -0.19 0.11 -0.08 0.06
Arm*Time 0.04 0.04 0.02 0.03 0.03 0.04 0.02 0.03 -0.03 0.05 -0.01 0.03
Random variance:
Intercept 0.90 0.09 0.96 0.08 0.86 0.08 0.49 0.05 0.82 0.10 0.25 0.03
Linear slope (Time) 0.06 0.02 0.05 0.01 0.07 0.01 0.04 0.01 0.09 0.02 0.03 0.01
Residual 0.74 0.03 0.49 0.02 0.50 0.02 0.35 0.02 0.89 0.04 0.25 0.01
SE = standard error
a All parameter entries are restricted maximum likelihood estimates fitted using Stata/SE12.1 xtmixed
* p \ 0.05; ** p \ 0.01;  p \ 0.001
2922 AIDS Behav (2013) 17:2914–2926
123
intervention specifically designed for substance using
MSM. As such, the new intervention did not perform at
levels above and beyond one of the more powerful evi-
dence-based risk-reduction interventions available to the
field. However, the similarity of effects between study arms
also suggests that brief interventions—delivered in the
context of a friendly and comfortable field office staffed by
MSM age peers—enable even very high risk MSM to
access mechanisms to reduce risk. In this study, the brief
intervention condition took *40 min to complete, and had
higher uptake than the group condition. The logistics of
implementing the brief individual resilience counseling
condition were much simpler, and this intervention format
would be much more easily implemented, scalable and
sustainable in community settings.
Our finding that Black men reduced their sexual risk
behaviors to a greater extent than White and Hispanic men,
despite exhibiting no higher levels of risk at baseline, bears
further investigation. Black men reported higher frequen-
cies of using drugs/binge drinking for sex, as well as higher
levels of substance dependence symptoms, than other men
at baseline, but they also reduced their drugs/binge drink-
ing—sex frequencies at a faster rate than White and His-
panic men. As reported elsewhere [35], African American/
Black men in the study commonly reported the importance
of social support to their health and health behaviors,
including the unique support they found through their
contact with project staff. Moreover, they perceived their
baseline levels of social support outside of the project
staff—as a group—to be much lower than among White
and Hispanic men. It is possible that the supportive envi-
ronment offered by the field office, including regular
contact from staff and extensive referrals to health and
social services, had a stronger effect on helping Black men
reduce risk compared to White and Latino men. We
acknowledge that a small proportion of our sample was
Black MSM, potentially reducing the generalizability of
this finding.
Limitations
Although the recruitment procedures resulted in a sample
of a wide age range and broadly inclusive of the racial/
ethnic makeup of South Florida, our ability to generalize
the findings to other MSM is limited by the study eligibility
requirements, including regular substance use and recent
UAI. Syndemic characteristics are likely much more pre-
valent among high risk substance users than among MSM
Table 3 Baseline to 12 month change scores for primary and secondary outcomes
BL
(N = 515)
3 Mo FUA
(N = 467)
6 Mo. FUA
(N = 459)
12 Mo. FUA
(N = 453)
BL-12 Mo
Mean
Effect CI for E.S.
difference
p
Mean (sd) Mean (sd) Mean (sd) Mean (sd) Difference Sizea Lower Upper
HIV trans. risk frequency
Control group: 18.89 37.03 8.52 18.35 8.73 20.7 9.42 28.76 9.48 0.71 0.58 0.83 \0.001
Experimental group: 13.92 25.21 7.80 16.70 7.34 19.13 7.55 17.23 6.38 0.66 0.53 0.78 \0.001
Unprotected anal sex frequency
Control group: 26.24 41.79 13.79 26.84 14.39 26.92 14.78 33.24 11.47 0.74 0.61 0.86 \0.001
Experimental group: 18.75 26.76 11.14 18.34 10.76 21.47 11.63 21.9 7.12 0.73 0.61 0.85 \0.001
Receptive trans. risk frequency
Control group: 8.79 22.11 3.67 8.62 3.92 11.3 4.02 11.15 4.77 0.46 0.35 0.57 \0.001
Experimental group: 7.22 17.49 3.62 11.11 3.30 13.79 3.50 10.49 3.72 0.43 0.32 0.54 \0.001
Insertive trans. risk frequency
Control group: 10.11 26.33 4.85 13.54 4.80 13.91 5.40 22.14 4.71 0.54 0.43 0.65 \0.001
Experimental group: 6.70 12.70 4.18 11.54 4.04 12.02 4.05 11.61 2.65 0.52 0.42 0.63 \0.001
Anal sex partners
Control group: 14.50 21.27 5.57 9.09 6.39 19.51 4.84 8.63 9.66 1.04 0.95 1.12 \0.001
Experimental group: 11.94 15.19 5.82 9.81 5.17 9.97 5.25 12.04 6.69 0.98 0.89 1.06 \0.001
Drugs/drunk for sex frequency
Control group: 44.82 59.84 24.45 46.39 22.96 42.03 17.39 31.7 27.43 0.94 0.81 1.06 \0.001
Experimental group: 42.94 68.01 15.28 33.36 15.15 31.08 13.87 24.08 29.08 1.00 0.87 1.13 \0.001
DSM dependence symptoms
Control group: 2.90 2.42 2.00 2.15 2.06 2.19 1.68 2.04 1.22 0.49 0.42 0.56 \0.001
Experimental group: 2.68 2.38 1.73 1.95 1.60 1.97 1.59 2.08 1.09 0.53 0.47 0.60 \0.001
a Effect size (Cohen’s d) and related 95 % confidence intervals are for log-transformed measures
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in general, and the study interventions may have been
particularly well-suited to men with high levels of mental
distress, social isolation, and victimization histories. We
also note that all data are based on self-report, potentially
leading to underreporting of socially undesirable behaviors.
Given the high levels of substance use and sexual risk
behaviors we found, however, underreporting of these and
other stigmatized behaviors would appear to be uncom-
mon. Moreover, men reported reductions in substance
dependence symptoms over time that accompanied their
reported reductions in substance use.
Another limitation of the study is that the RESPECT
model was enhanced to include resilience-based approa-
ches to risk reduction, and as such was perhaps more robust
than a true standard of care. As such, the efficacy of the
experimental condition compared to a true standard of care
cannot be measured.
Implications for Future Research
Our study results are similar in some ways to other
behavioral intervention trials for substance-using MSM
[12–14]. Stall et al. reported no differences in sexual risk
outcomes among substance abuse treatment clients assigned
in a modified random design to a standard recovery group
format or a recovery group enhanced to include sexual risk
reduction protocols. In a four-arm randomized trial for
MSM treatment enrollees, Shoptaw and colleagues found
that contingency management, with or without cognitive
behavioral therapy (CBT), was more efficacious for client
retention, duration and continuity of clean urines, and
reducing unprotected receptive anal intercourse than CBT
alone, although changes in drug use were not different
across conditions. In a two-armed RCT of a group-based
CBT intervention compared to a time-matched control, that
also included a non-randomized third group receiving HIV
testing and counseling alone, Mansergh et al. reported no
statistical differences in sexual risk or substance use
reduction across study arms. As the latter and the present
studies are the only two of the four to target not-in-treatment
MSM, clearly new behavioral approaches are needed for
non-treatment populations of MSM substance users.
However, each of these studies demonstrated high and
sustained levels of risk reduction in both the experimental
and control conditions. In all of four studies, the reductions
were evident at the first follow-up and sustained through the
final assessment. These similarities are striking and suggest
that substance using MSM can initiate and sustain substantial
risk reductions, but that the processes by which these men
reduce their risks are poorly understood. Basic research that
describes how these reductions occur over time may prove to
be the best investment that the field could make in designing
interventions for this population. A more comprehensive
understanding of the factors that contribute to risk reductions
among high risk MSM substance users in control arms is
needed to inform the design of low threshold interventions
that could be broadly disseminated.
In the present study, one possible explanation is that
both intervention conditions, despite varying significantly
in dose and mode of delivery, were focused on participants’
self-identification of strengths and needs, and provided
high levels of social support and extensive referrals to
health and social services. Other possible explanations
include the experience of study enrollment alone, self-
selection into research studies of participants who are ready
to change, and/or reactive effects to study assessments [36–
39]. Although several HIV RCT outcome reports have
suggested such potentially confounding effects [14, 16, 40–
43], their measurement in the HIV prevention research
literature is scant (see [39, 42, 44]), and is not apparent in
studies of high risk MSM substance users.
So-called reactive effects of research and/or clinical
assessments among substance users have been recognized in
the literature since at least the mid-1970s [37]. Researchers
studying both substance abuse and sexual risk behaviors
have attributed these behavioral responses to assessments to
consciousness raising, focused attention, self-monitoring,
self-efficacy, and similar phenomena [36, 37, 40, 42, 45].
Indeed, qualitative data from young adult multidrug users
who recently completed a large-scale natural history study
conducted by the investigators attributed their extensive
reductions in substance use to increased self-awareness that
emerged in response to the comprehensive health and social
risk assessments [46]. Largely missing from this literature is
systematic empirical evidence for how and why study
assessments might produce behavior change [36, 45].
This analysis points to several potentially important
strategies for future research designs of RCTs of interven-
tions to assist high risk MSM reduce their health risk
behaviors: (1) the inclusion of wait list and assessment-only
conditions, so that enrollment, assessment and intervention
effects can be clearly evaluated; and (2) more extensive
qualitative data collection from study completers to contex-
tualize motivations and mechanisms of behavior change. The
overarching aim should be to identify the least intensive and
most effective behavioral interventions that can be scaled up
in community settings, as well as provide the necessary and
complementary support for treatment as prevention [47], pre-
exposure prophylaxis [48], and other emerging biological
prevention approaches to be effective [49].
Conclusion
MSM suffer the majority of new HIV infections in the
United States, and a substantial proportion of these new
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infections occur among substance-using MSM. The men
sampled for this trial not only reside in a region charac-
terized by one of the highest HIV incidence rates for MSM
in the United States, but are men who also reported
exceptionally high levels of sexual risk-taking. Given that
these men reside in an area that attracts enormous numbers
of gay male tourists, it is likely that the sexual risk-taking
behaviors of substance-using MSM in South Florida have
epidemiological repercussions not only locally but far
beyond Florida’s borders. We now have data from four
separate studies to show that rates of sexual risk-taking
among MSM substance users can be reduced to an
impressive degree, and that these risk reductions are stable
for relatively long periods of time. These findings—and the
larger epidemiological contexts of HIV risk among sub-
stance-using MSM—suggest that interventions can be
designed to reduce HIV transmission risk in this popula-
tion, and, moreover, that continued attempts to lower HIV
infection rates among MSM substance users could prove to
be an essential tool to reduce HIV-related health disparities
among the broad population of MSM in the United States.
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